Market Overview

UPDATE: JP Morgan Upgrades Thermo Fisher Scientific to Overweight on Favorable Risk/Reward

Share:
Related TMO
Benzinga's Top Upgrades, Downgrades For May 19, 2017
Wall Street's M&A Chatter From May 15: Thermo Fisher-Patheon, La Quinta, China Automotive Systems

JP Morgan upgraded Thermo Fisher Scientific (NYSE: TMO) from Neutral to Overweight and raised the price target from $70.00 to $80.00.

JP Morgan noted, "We are upgrading Thermo Fisher Scientific (TMO) from Neutral to Overweight on favorable risk/reward due to conservative guidance that should be at worst achievable, and more likely beatable, and an improving record of capital deployment since management has increasingly focused on the higher bar of ROIC, rather than simply adjusted EPS accretion. The company's robust and growing free cash flow provides clear optionality around additional capital deployment, including but not limited to recent press reports (Reuters) that it is now evaluating a purchase of Life Technologies (LIFE)."

Thermo Fisher Scientific closed at $72.14 on Thursday.

Latest Ratings for TMO

DateFirmActionFromTo
May 2017Cantor FitzgeraldInitiates Coverage OnOverweight
Jan 2017Deutsche BankInitiates Coverage OnBuy
Jan 2017Deutsche BankInitiates Coverage OnBuy

View More Analyst Ratings for TMO
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Analyst Ratings

 

Related Articles (TMO)

View Comments and Join the Discussion!